iTeos Therapeutics: Commitment to corporate responsibility

As a responsible company, we are committed to building Environmental, Social and Governance (ESG) principles into how we operate to create sustainable value for society and all of our stakeholders. Each member of the iTeos family is a vital contributor to achieving our mission of improving the lives of people with cancer. Knowing that together we are stronger, we are committed to a healthy and productive workforce, diversity and inclusion, employee engagement and talent development, and reducing our environmental footprint and preserving precious resources.

To read further please view our 2022 report.

scientist filling test tubes at a bench

We work together to develop breakthrough therapies to treat cancer through improving the immune response.

We bring our deep understanding of the tumor microenvironment and immunosuppressive pathways to design new products and improve the clinical benefit of oncology therapies.

Driven by a culture of scientific innovation, collaboration and excellence, together we discover and deliver breakthrough immunotherapies to improve and extend the lives of people with cancer.